Clinical trial
Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem…
NCT00079339 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00079339 |
|---|---|
| Title | Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma |
| Official title | Phase I/II Trial of R115777 and XRT in Pediatric Patients With Newly Diagnosed Non-Disseminated Intrinsic Diffuse Brainstem Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Untreated Childhood Brain Stem Glioma |
| Intervention type | Drug, Radiation |
| Interventions | radiation therapy, tipifarnib |
| Enrollment | 51 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Mar 10, 2004 |
| Last update posted | May 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: